Christiana Stamoulis, SVP, Corporate Strategy & Business Devlp at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,125 shares at $87.33 ($97K) on 2013-07-15, disclosed to the SEC on 2013-07-17.
Scheduled sale ($97k) by SVP, Corporate Strategy & Business Devlp under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.25 | 1,025 | $88K | 91.0% |
| 2 | $87.33 | 100 | $9K | 9.0% |
| Total | $86.35 avg | 1,125 | $97K | 100% |
| Filing → |
| HOLX | SELL | 2020-11-06 | $825K | — | Filing → |
| HOLX | SELL | 2019-11-26 | $1.2M | — | Filing → |
| HOLX | SELL | 2018-11-30 | $1.2M | — | Filing → |